Format

Send to

Choose Destination
Ann Oncol. 2016 Jan;27(1):199-200. doi: 10.1093/annonc/mdv496. Epub 2015 Oct 20.

A clinical case of invasive lobular breast carcinoma with ERBB2 and CDH1 mutations presenting a dramatic response to anti-HER2-directed therapy.

Author information

1
Department of Medical Oncology, Institut Bergonié, Bordeaux.
2
Department of Pathology, Institut Bergonié, Bordeaux.
3
INSERM U916, Institut Bergonié, University of Bordeaux, Bordeaux, France.
4
Department of Medical Oncology, Institut Bergonié, Bordeaux a.italiano@bordeaux.unicancer.fr.
PMID:
26487584
DOI:
10.1093/annonc/mdv496
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center